Conversation with The Cancer Letter Ben Ho Park wants Vanderbilt to deliver precision oncology in Tennessee—and globally September 30, 2022Vol.48 No.35By Paul Goldberg
Conversation with The Cancer Letter 25M Americans live outside cancer centers’ catchment areas, AACI-Jefferson study finds September 30, 2022Vol.48 No.35By Matthew Bin Han Ong
ODAC nixes three cancer drug indications, citing dose uncertainty September 30, 2022Vol.48 No.35By Jacquelyn Cobb
Free How Florida cancer hospitals are responding to Hurricane Ian September 30, 2022Vol.48 No.35By Alexandria Carolan
FreeIn the Archives Katrina, Irma, Harvey: How oncology responds to hurricanes September 30, 2022Vol.48 No.35
2022 Lasker Awards winners are: Richard O. Hynes, Erkki Ruoslahti, Timothy A. Springer, Yuk Ming Dennis Lo, Lauren Gardner September 30, 2022Vol.48 No.35
Conversation with The Cancer Letter Jefferson’s Andrew Chapman tells us what it’s like to be the first geriatric oncology expert to run a cancer center September 23, 2022Vol.48 No.34By Paul Goldberg
Conversation with The Cancer Letter FDA spells out new systematic approach to giving out–and taking away–accelerated approvals in oncology September 23, 2022Vol.48 No.34By Paul Goldberg
Guest Editorial Data presented at ESMO strengthens concern that the labeled dose of sotorasib is not optimal September 23, 2022Vol.48 No.34By Mark J. Ratain, Garth W. Strohbehn, Ian F. Tannock and Allen S. Lichter
NCI Lowy’s AACR keynote: “Unacceptable” disparities in cancer outcomes mar 21st century progress September 23, 2022Vol.48 No.34By Matthew Bin Han Ong
